CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan · Delayed Price · Currency is TWD 90.90
-0.40 (-0.44%)
Jun 5, 2026, 9:23 AM CST
CH Biotech R&D Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,386 | 9,252 | 8,306 | 8,275 | 7,320 | 5,150 | |
Market Cap Growth | 16.16% | 11.39% | 0.37% | 13.05% | 42.15% | 20.79% |
Enterprise Value | 9,378 | 9,704 | 8,439 | 8,371 | 7,556 | 5,884 |
Last Close Price | 91.30 | 85.86 | 73.40 | 70.18 | 61.91 | 42.71 |
PE Ratio | 19.14 | 19.94 | 17.44 | 17.86 | 15.73 | 17.67 |
PS Ratio | 5.11 | 5.09 | 5.08 | 5.46 | 5.10 | 5.06 |
PB Ratio | 3.51 | 3.45 | 3.14 | 3.28 | 3.51 | 2.99 |
P/TBV Ratio | 3.53 | 3.46 | 3.15 | 3.29 | 3.52 | 3.00 |
P/FCF Ratio | 16.14 | 19.87 | - | 15.17 | 12.51 | 26.76 |
P/OCF Ratio | 13.09 | 15.71 | 15.43 | 12.56 | 10.47 | 19.48 |
EV/Sales Ratio | 5.11 | 5.33 | 5.16 | 5.53 | 5.27 | 5.78 |
EV/EBITDA Ratio | 10.85 | 12.02 | 11.97 | 11.90 | 12.03 | 13.50 |
EV/EBIT Ratio | 14.47 | 15.57 | 15.56 | 14.79 | 14.78 | 16.38 |
EV/FCF Ratio | 16.13 | 20.84 | - | 15.35 | 12.91 | 30.58 |
Debt / Equity Ratio | 0.19 | 0.25 | 0.28 | 0.34 | 0.43 | 0.65 |
Debt / EBITDA Ratio | 0.60 | 0.79 | 1.02 | 1.16 | 1.38 | 2.47 |
Debt / FCF Ratio | 0.89 | 1.43 | - | 1.55 | 1.53 | 5.83 |
Net Debt / Equity Ratio | -0.04 | 0.10 | 0.10 | -0.04 | 0.17 | 0.46 |
Net Debt / EBITDA Ratio | -0.13 | 0.33 | 0.38 | -0.14 | 0.58 | 1.83 |
Net Debt / FCF Ratio | -0.19 | 0.57 | -5.31 | -0.18 | 0.62 | 4.13 |
Asset Turnover | 0.45 | 0.51 | 0.45 | 0.44 | 0.46 | 0.35 |
Inventory Turnover | 2.49 | 2.12 | 2.25 | 1.72 | 1.98 | 2.04 |
Quick Ratio | 0.89 | 0.97 | 1.08 | 1.24 | 1.30 | 0.98 |
Current Ratio | 1.08 | 1.21 | 1.32 | 1.40 | 1.72 | 1.24 |
Return on Equity (ROE) | 18.34% | 17.39% | 18.41% | 20.11% | 24.43% | 18.20% |
Return on Assets (ROA) | 9.94% | 10.81% | 9.31% | 10.33% | 10.26% | 7.60% |
Return on Invested Capital (ROIC) | 19.24% | 17.32% | 16.31% | 18.59% | 16.92% | 11.72% |
Return on Capital Employed (ROCE) | 23.20% | 21.80% | 18.20% | 20.50% | 18.70% | 14.40% |
Earnings Yield | 5.23% | 5.01% | 5.73% | 5.60% | 6.36% | 5.66% |
FCF Yield | 6.19% | 5.03% | -0.60% | 6.59% | 7.99% | 3.74% |
Dividend Yield | 5.25% | 5.59% | 5.59% | 5.83% | 6.27% | 3.05% |
Payout Ratio | 85.79% | 90.84% | 77.47% | 102.26% | 27.21% | 14.48% |
Buyback Yield / Dilution | - | 0.05% | -5.50% | 0.77% | -0.54% | -0.44% |
Total Shareholder Return | 5.25% | 5.64% | 0.08% | 6.60% | 5.73% | 2.61% |